Cdmo Packaging Market: Size, Share and Growth Report (2025–2034)

Market Overview

The CDMO packaging market is witnessing consistent growth as pharmaceutical and biotechnology companies increasingly outsource packaging operations to Contract Development and Manufacturing Organizations (CDMOs). Integrated packaging services offered by CDMOs help streamline drug development and commercialization while ensuring compliance with evolving regulatory standards. The global CDMO packaging market reached USD 14.6 billion in 2025 and is projected to grow to USD 15.9 billion in 2026. Supported by expanding pharmaceutical outsourcing and rising demand for specialized packaging services, the market is expected to reach approximately USD 36.8 billion by 2034, registering a CAGR of 9.8% during the forecast period. Growing demand for biologics, specialty drugs, and advanced pharmaceutical packaging solutions continues to drive market expansion.

Request Sample Link:

https://packagingmarketinsights.com/report/cdmo-packaging-market/request-sample

Market Size and Forecast

The global Cdmo Packaging Market was valued at USD 14.6 billion in 2025 and is projected to increase to USD 15.9 billion in 2026. Increasing reliance on outsourced pharmaceutical packaging services and growing demand for integrated CDMO solutions are expected to drive the market to approximately USD 36.8 billion by 2034.

The market is forecast to register a compound annual growth rate (CAGR) of 9.8% during the forecast period. Continued advancements in packaging technologies, serialization systems, cold chain solutions, and regulatory-compliant packaging are expected to support long-term market growth.

Market Drivers

Increasing Outsourcing by Pharmaceutical Companies

The growing outsourcing of packaging operations by pharmaceutical companies is one of the primary drivers of the CDMO packaging market. Pharmaceutical manufacturers are partnering with CDMOs to reduce operational costs, improve efficiency, and accelerate product commercialization. Outsourcing enables companies to utilize specialized infrastructure and packaging expertise while focusing on core research and development activities.

Rising Demand for Complex and Biologic Drug Packaging

The increasing demand for biologics and complex pharmaceutical products is another key growth driver. These products require specialized packaging solutions capable of maintaining sterility, stability, and product integrity throughout storage and distribution. CDMOs are providing customized packaging services that meet these stringent pharmaceutical requirements.

Market Challenges

Stringent Regulatory Requirements and Compliance Costs

Strict regulatory requirements related to pharmaceutical labeling, safety, traceability, and serialization remain a major challenge for the CDMO packaging market. Compliance often requires substantial investments in advanced equipment, validation procedures, digital infrastructure, and documentation. Frequent regulatory updates also increase operational complexity, particularly for smaller CDMOs with limited financial resources.

Market Opportunities

Expansion of CDMO Services in Emerging Markets

Rapid expansion of pharmaceutical manufacturing across emerging economies presents significant opportunities for CDMO service providers. Increasing healthcare expenditure, supportive government initiatives, and growing pharmaceutical production in the Asia Pacific and Latin America are creating favorable conditions for expanding outsourced packaging services.

Adoption of Sustainable Packaging Solutions

Growing demand for environmentally responsible pharmaceutical packaging is creating additional market opportunities. Pharmaceutical companies are increasingly adopting recyclable and biodegradable packaging materials, encouraging CDMOs to invest in sustainable packaging technologies and innovative material solutions that reduce environmental impact while maintaining product safety.

Market Segmentation

By Packaging Type

• Primary Packaging

• Secondary Packaging

• Tertiary Packaging

Primary packaging dominated the market in 2024, accounting for approximately 57% of the total market share due to its direct contact with pharmaceutical products and strict quality requirements. The secondary packaging segment is expected to register the fastest CAGR of 10.1% during the forecast period, supported by increasing demand for advanced labeling, branding, and product protection solutions.

By Service Type

• Packaging Design and Development

• Labeling and Serialization

• Assembly and Distribution

Packaging design and development accounted for approximately 45% of total revenue in 2024 as pharmaceutical companies increasingly required customized packaging solutions. The labeling and serialization segment is projected to witness the fastest growth, registering a CAGR of 10.3% during the forecast period due to expanding regulatory requirements for traceability and anti-counterfeiting.

By End-Use

• Pharmaceutical Companies

• Biotechnology Companies

• Others

Pharmaceutical companies represented approximately 60% of the market share in 2024 as outsourcing packaging operations became increasingly common. Biotechnology companies are expected to be the fastest-growing end-user segment, expanding at a CAGR of 10.4% during the forecast period because of rising demand for biologics and specialized pharmaceutical packaging.

Regional Analysis

North America accounted for approximately 40% of the CDMO packaging market in 2025 and is expected to grow at a CAGR of 9.2% during the forecast period. The United States leads the regional market due to its advanced pharmaceutical industry, strong healthcare infrastructure, and widespread adoption of serialization technologies.

Europe held approximately 25% of the market share in 2025 and is projected to expand at a CAGR of 9.5%. Germany remains the leading market in the region, supported by its strong pharmaceutical manufacturing base and increasing emphasis on sustainable packaging solutions.

Asia Pacific represented around 23% of the global market in 2025 and is expected to register the highest CAGR of 10.5% during the forecast period. China dominates the regional market because of expanding pharmaceutical manufacturing capabilities and increasing outsourcing activities supporting CDMO growth.

The Middle East & Africa accounted for approximately 6% of the market share in 2025 and is expected to grow at a CAGR of 8.4%. The United Arab Emirates is a key market due to improving healthcare infrastructure and growing adoption of advanced pharmaceutical packaging technologies.

Latin America represented around 6% of the global market in 2025 and is projected to expand at a CAGR of 8.7%. Brazil leads the regional market as pharmaceutical manufacturing continues to expand and outsourcing trends strengthen across the region.

Key Players

• Catalent, Inc.

• Lonza Group AG

• Thermo Fisher Scientific Inc.

• Recipharm AB

• Samsung Biologics

• Almac Group

• Jubilant HollisterStier LLC

• Piramal Pharma Solutions

Conclusion

The CDMO packaging market is positioned for sustained growth as pharmaceutical and biotechnology companies increasingly rely on outsourcing partners for specialized packaging services. Rising demand for biologics, serialization technologies, cold chain packaging, and regulatory-compliant pharmaceutical packaging continues to support market expansion. Although stringent regulatory requirements and compliance costs remain significant challenges, growing pharmaceutical manufacturing activities and increasing adoption of sustainable packaging solutions present substantial opportunities for CDMO service providers.

Report Link:

https://packagingmarketinsights.com/report/cdmo-packaging-market

With the market projected to grow from USD 14.6 billion in 2025 to approximately USD 36.8 billion by 2034 at a CAGR of 9.8%, the CDMO Packaging Market is expected to benefit from continued pharmaceutical outsourcing, technological advancements, and increasing demand for integrated, compliant, and specialized packaging solutions.